Candriam SCA’s Kodiak Sciences KOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-33,186
Closed -$2.81M 828
2021
Q4
$2.81M Hold
33,186
0.02% 479
2021
Q3
$3.19M Hold
33,186
0.02% 483
2021
Q2
$3.09M Sell
33,186
-112,483
-77% -$10.8M 0.02% 504
2021
Q1
$20.6M Hold
145,669
0.17% 143
2020
Q4
$21.4M Sell
145,669
-220,679
-60% -$24.6M 0.17% 144
2020
Q3
$21.7M Sell
366,348
-32,159
-8% -$1.61M 0.2% 127
2020
Q2
$21.6M Buy
398,507
+384,160
+2,678% +$21.7M 0.23% 112
2020
Q1
$1.01M Hold
14,347
0.01% 649
2019
Q4
$1.03M Sell
14,347
-240,153
-94% -$8.74M 0.01% 666
2019
Q3
$3.66M Buy
+254,500
New +$3.32M 0.05% 381

Other funds holding KOD

Candriam SCA's KOD Position: Q1 2022 in Review

Candriam SCA sold out of Kodiak Sciences (KOD) in Q1 2022, closing a stake of 33,186 shares — an estimated $2.81M sold.

Candriam SCA first reported a position in KOD in Q3 2019 and held it in 10 quarters. The position peaked at $21.7M in Q3 2020. 142 funds tracked by Wall St. Rank hold KOD as of Q1 2022.

  • Candriam SCA reported no remaining Kodiak Sciences position as of Q1 2022 after selling out during the quarter.
  • Candriam SCA sold 33,186 Kodiak Sciences shares in Q1 2022, an estimated $2.81M.
  • Candriam SCA first reported a position in Kodiak Sciences in Q3 2019 and held it in 10 quarters.
  • Candriam SCA's Kodiak Sciences position peaked at $21.7M in Q3 2020.
  • 142 funds tracked by Wall St. Rank held Kodiak Sciences as of Q1 2022.

Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.